Zobrazeno 91 - 100
of 307
pro vyhledávání: '"Francesco Forconi"'
Autor:
Tanya S. Rosenberg, Stan Fort, Simon Sharmokh, Mary Ann Anderson, Fatih Demirkan, Arnon P. Kater, Yair Herishanu, Nikitin Ea, Francesco Forconi, Tara Cochrane, Matthew S. Davids, Abdullah A. Masud, Brian Leber
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S220
Background Neutropenia is a common hematologic Grade (Gr) 3+ adverse event (AE) recorded in patients with chronic lymphocytic leukemia (CLL) receiving venetoclax (VEN). In this analysis, we evaluated fixed duration VEN monotherapy given to patients w
Autor:
Francesca Arruga, Valeria Bracciamà, Nicoletta Vitale, Tiziana Vaisitti, Katiuscia Gizzi, Alison Yeomans, Marta Coscia, Giovanni D’Arena, Gianluca Gaidano, John N. Allan, Richard R. Furman, Graham Packham, Francesco Forconi, Silvia Deaglio
Publikováno v:
Leukemia. 34:1721-1721
Autor:
Hanneke ter Burg, Gabriela Andrejeva, Gerritje J. W. van der Windt, Arnon P. Kater, Zhenghao Chen, Eric Eldering, Jeffrey C. Rathmell, Francesco Forconi, Gaspard Cretenet
Publikováno v:
Blood. 134:479-479
Chronic lymphocytic leukemia (CLL) has become a paradigm for a cancer that depends on signals from the microenvironment. In lymph nodes (LN), CLL cells receive from surrounding cells proliferative and pro-survival signals, which can protect against c
Autor:
Isla Henderson, Laura Ondrisova, Ian Tracy, Marek Mráz, David Dutton, Andrew J. Steele, Peter Johnson, Annalisa D'Avola, Graham Packham, Andrew S Duncombe, Giorgia Chiodin, Lesley-Ann Sutton, Jonathan C. Strefford, Matthew J. J. Rose-Zerilli, Silvia Bonfiglio, Samantha Drennan, Christina Pitsillidou, Helen Parker, Paolo Ghia, Lydia Scarfò, Enrica Antonia Martino, Freda K. Stevenson, Francesco Forconi
Publikováno v:
Blood. 134:1752-1752
The circulating tumor cells of chronic lymphocytic leukemia (CLL) are characterized by variably low surface IgM (sIgM) levels and signaling capacity, consequent to stimulation by tissue-based antigen. The variability is evident in both CLL subsets wi
Autor:
Colin Shepherd, Thahira Rahman, Timothy M. Barrow, Sarah E. Fordham, Pauline Robbe, Nicola J. Sunter, Peter Hillmen, David Oscier, Andrew R. Pettitt, Gordon Strathdee, April Sellors, Guy Pratt, Chris Pepper, Jonathan P. Wallis, Christopher Fegan, Helen Marr, Scott Marshall, Anna Schuh, Geoffery Summerfield, Wei-Yu Lin, Syed Ashar Rais, David Allsup, Richard S. Houlston, Lynn Cawkwell, Claire Elstob, Sandrine Jayne, Martin J. S. Dyer, James R. Bailey, Tryfonia Mainou-Fowler, James M. Allan, Elaine Willmore, Alison Bentley, Rachel Piddock, Francesco Forconi
Publikováno v:
Blood. 134:1740-1740
The increased incidence of chronic lymphocytic leukemia (CLL) in first-degree relatives of affected patients indicates an element of genetic susceptibility to this malignancy, borne out in large scale genome-wide association studies (GWAS), which hav
Autor:
Graham Packham, Teunis B.H. Geijtenbeek, Philip J Rock, Freda K. Stevenson, Carl G. Figdor, Giorgia Chiodin, Francesco Forconi, Beatriz Valle Argos, Richard Burack, Patrick J. Duriez, Enrica Antonia Martino, Max Crispin, Joel D. Allen
Publikováno v:
Blood. 134:1505-1505
Diffuse large B-cell lymphomas (DLBCL) are a heterogeneous diagnostic entity of B-cell tumors whose behavior is variably influenced by genetic changes and environmental stimuli. They are usually divided into two major subgroups, the germinal center B
Autor:
Massimo Gentile, Bernhard Gerber, Davide Rossi, Richard Rosenquist, Fortunato Morabito, Kari G. Rabe, Clara Deambrogi, Michael Hallek, Gianluca Gaidano, Mattias Mattsson, Michael Doubek, William G. Wierda, Lorenzo De Paoli, Sameer A. Parikh, Georg Stussi, Jasmin Bahlo, Riccardo Moia, Šárka Pospíšilová, Alessio Bruscaggin, Carmen D. Herling, Lodovico Terzi di Bergamo, Michele Ghielmini, Elena Bianchi, Antonino Neri, Giorgia Chiodin, Giovanna Cutrona, Manlio Ferrarini, Emili Montserrat, Francesco Forconi, Jana Kotašková, Adalgisa Condoluci, Petra Langerbeins, Valeria Spina, Francesca Romana Mauro, Manuela Hoechstetter, Emanuele Zucca, Julio Delgado, Robin Foà, Franco Cavalli
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:S278
Autor:
Francesco Forconi
Publikováno v:
Blood. 131(21)
The safety and efficacy of ibrutinib (420 mg) in chronic lymphocytic leukemia (CLL) were evaluated in a phase 2 study; 51 patients had TP53 aberration (TP53 cohort) and 35 were enrolled because of age 65 years or older (elderly cohort). Both cohorts
Autor:
Alison Yeomans, Gianluca Gaidano, Francesca Arruga, Giovanni D'Arena, Graham Packham, Francesco Forconi, Valeria Bracciamà, Marta Coscia, Annalisa D'Avola, Silvia Deaglio, John N. Allan, Richard R. Furman
BACKGROUND. Mutations in NOTCH1 PEST domain (NOTCH1-M) are present in ~10% of Chronic Lymphocytic Leukemia (CLL) patients, result in accumulation of more stable NOTCH1 protein, and associate with poorer prognosis. NOTCH1-M are enriched in unmutated (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80a663bb31812253217f81ef7c861008
http://hdl.handle.net/2318/1807153
http://hdl.handle.net/2318/1807153
Autor:
Arnon P. Kater, Francesco Forconi, Gabriela Andrejeva, G.J. W. van der Windt, Zhenghao Chen, H. ter Burg, Jeffrey C. Rathmell, Eric Eldering
Publikováno v:
HemaSphere. 3:509-510